Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers.

D N Waterhouse; K A Gelmon; R Klasa; K Chi; D Huntsman; E Ramsay; E Wasan; L Edwards; C Tucker; J Zastre

doi:10.2174/156800906778194586

Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers.

Identifier:nobleid.org/w1/20260515/B803F0EE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B803F0EE.svg?ark=w1%2F20260515%2FB803F0EE)](https://nobleid.org/work/w1/20260515/B803F0EE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers.

Identifier:nobleid.org/w1/20260515/B803F0EE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B803F0EE.svg?ark=w1%2F20260515%2FB803F0EE)](https://nobleid.org/work/w1/20260515/B803F0EE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work